FPIN's Clinical Inquiries
Intra-articular Corticosteroid Injections for Osteoarthritis of the Knee
Am Fam Physician. 2014 Jul 15;90(2):115-116.
How effective and safe are intra-articular corticosteroid injections for the treatment of osteoarthritis of the knee?
Intra-articular corticosteroid injections can be used to reduce pain by about 20% in the short term (one to three weeks) in patients with osteoarthritis of the knee. (Strength of Recommendation [SOR]: A, based on a meta-analysis of randomized controlled trials.) Intra-articular injections cause joint infections in one out of 14,000 to 77,000 procedures and can result in hyperglycemia for two to three days in patients with diabetes mellitus. Injections should not be given more often than every three months. (SOR: C, based on expert opinion.)
A meta-analysis of 13 randomized controlled trials comparing a single corticosteroid injection with placebo in patients with osteoarthritis of the knee showed improvement in pain but not in function at one week. There was no improvement in any parameter at longer intervals.1 Patients were recruited from the United States, Canada, France, and England. Women comprised 62% to 71% of the study participants, and the average age was 60 to 71 years. Eight of the trials (N = 397) evaluated pain. Three trials that used a visual analog scale showed improvements at one week (weighted mean difference = −22 points on a scale of 1 to 100; 95% confidence interval, −30 to −14), but not at four or six weeks. Four studies compared the percentage of patients with reduced pain after a corticosteroid injection compared with those who had a placebo injection. One trial showed a nonsignificant difference at one week, and another found reduced pain with steroids at one week but no difference at four weeks (number needed to treat [NNT] = 2.6). One trial showed reduced pain at two weeks after a corticosteroid injection, and one found reduced pain at three weeks (NNT = 3). Three studies that measured range of motion and walking distance or time (N = 251) found no significant differences for up to 24 weeks.
A systematic review found no significant differences in withdrawal rates, number of postinjection steroid flares, or local discomfort.1 A randomized trial of patients with osteoarthritis who received intra-articular corticosteroid or saline injections found no difference in radiographic appearances between the groups.2 A cohort study of 65 patients with osteoarthritis who were given multiple corticosteroid injections and followed for up to 20 years found no correlation between the frequency of injections and deterioration on radiography.3
Joint Infection. A retrospective study asked 69 rheumatologists to recall all episodes of joint infection after intra-articular corticosteroid injections that they performed during their careers (range, 10 to 20 years).4 They reported a total of 15 joint infections out of an estimated 1.6 million injections into a variety of joints (infection complication rate of approximately one in 77,300 injections). Another retrospective review cited in the meta-analysis above1 reported infection rates of one in 14,000 to 50,000 injections.
Short-Term Hyperglycemia in Patients with Diabetes. Two small cohort studies found that corticosteroid injections produced short-term elevations in glucose levels in patients with diabetes who have osteoarthritis. In the first study, seven of nine patients with well-controlled type 2 diabetes (A1C less than 7.0%) had glucose levels more than two standard deviations above baseline after a methylprednisone injection into the knee (peak levels at five to 84 hours after injection).5 In the second study, six out of six patients had hyperglycemia after an intra-articular betamethasone injection (peak glucose levels 251 to 430 mg per dL [13.9 to 23.9 mmol per L]).6
Recommendations from Others
The American College of Rheumatology recommends that intra-articular corticosteroid injections be administered no more often than every three months for patients with osteoarthritis whose symptoms are not controlled with full-dose acetaminophen.7 A guideline from the United Kingdom's National Collaborating Centre for Chronic Conditions recommends intra-articular corticosteroid injections in combination with exercise and weight loss for pain relief in patients with osteoarthritis.8
Copyright Family Physicians Inquiries Network. Used with permission.
REFERENCESshow all references
1. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006;(2):CD005328....
2. Raynauld JP, Buckland-Wright C, Ward R, et al. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2003;48(2):370–377.
3. Balch HW, Gibson JM, El-Ghobarey AF, Bain LS, Lynch MP. Repeated corticosteroid injections into knee joints. Rheumatol Rehabil. 1977;16(3):137–140.
4. Seror P, Pluvinage P, d'Andre FL, Benamou P, Attuil G. Frequency of sepsis after local corticosteroid injection (an inquiry on 1160000 injections in rheumatological private practice in France). Rheumatology (Oxford). 1999;38(12):1272–1274.
5. Habib GS, Bashir M, Jabbour A. Increased blood glucose levels following intra-articular injection of methylprednisolone acetate in patients with controlled diabetes and symptomatic osteoarthritis of the knee. Ann Rheum Dis. 2008;67(12):1790–1791.
6. Habib G, Safia A. The effect of intra-articular injection of betamethasone acetate/betamethasone sodium phosphate on blood glucose levels in controlled diabetic patients with symptomatic osteoarthritis of the knee. Clin Rheumatol. 2009;28(1):85–87.
7. Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64(4):465–474.
8. National Collaborating Centre for Chronic Conditions (UK). Osteoarthritis: national clinical guideline for care and management in adults. London, U.K.: National Institute for Health and Clinical Excellence; 2008.
Clinical Inquiries provides answers to questions submitted by practicing family physicians to the Family Physicians Inquiries Network (FPIN). Members of the network select questions based on their relevance to family medicine. Answers are drawn from an approved set of evidence-based resources and undergo peer review. The strength of recommendations and the level of evidence for individual studies are rated using criteria developed by the Evidence-Based Medicine Working Group (http://www.cebm.net/?o=1025).
The complete database of evidence-based questions and answers is copyrighted by FPIN. If interested in submitting questions or writing answers for this series, go to http://www.fpin.org or e-mail: firstname.lastname@example.org.
A collection of FPIN's Clinical Inquiries published in AFP is available at https://www.aafp.org/afp/fpin.
Want to use this article elsewhere? Get Permissions
More in AFP
MOST RECENT ISSUE
Sep 15, 2020
Access the latest issue of American Family Physician